Increase Consumer Prescription Drug Protections

Last updated: Jun 24, 2017

Details about this bill
Category: Pharmacy Related
Status: Defeated
Sponsor: Senator Eloise Vitelli, Senate 19 - Oxford County
Session: 128
Bill #: LD 1605

Position:

Monitoring.

UPDATE: This bill has been defeated.

Summary:

This bill requires the Maine Health Data Organization to annually identify, upon the request of the Attorney General, prescription drugs on which the State spends significant amounts of money and for which the manufacturer's list price for the drug has increased by 50% or more over the past 5 years or 15% or more over the past 12 months. The Maine Health Data Organization is required to provide the list to the Attorney General, who must require the manufacturer of the drugs to provide a justification for the increase.

The bill also prohibits manufacturers and wholesale distributors from price gouging in the sale of essential off-patent or generic drugs. It authorizes the Attorney General to obtain data from the Maine Health Data Organization concerning increases in prices of essential off-patent or generic drugs and requires manufacturers of essential off-patent or generic drugs to submit information to the Attorney General upon request of the Attorney General.